CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 27 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $5,515,000 | +137775.0% | 5,130,000 | +128150.0% | 0.00% | – |
Q1 2018 | $4,000 | -99.9% | 4,000 | -99.9% | 0.00% | -100.0% |
Q4 2017 | $5,542,000 | -0.6% | 4,119,000 | +13.8% | 0.00% | 0.0% |
Q3 2017 | $5,577,000 | +322.2% | 3,619,000 | +363.4% | 0.00% | +300.0% |
Q2 2017 | $1,321,000 | +13.3% | 781,000 | -13.9% | 0.00% | 0.0% |
Q1 2017 | $1,166,000 | -34.5% | 907,000 | -47.7% | 0.00% | 0.0% |
Q4 2016 | $1,781,000 | +88.5% | 1,734,000 | +73.4% | 0.00% | 0.0% |
Q3 2016 | $945,000 | +33.9% | 1,000,000 | 0.0% | 0.00% | – |
Q2 2016 | $706,000 | +4.1% | 1,000,000 | -0.1% | 0.00% | -100.0% |
Q1 2016 | $678,000 | -58.1% | 1,001,000 | -47.1% | 0.00% | 0.0% |
Q4 2015 | $1,617,000 | +99.4% | 1,892,000 | +289.3% | 0.00% | 0.0% |
Q3 2015 | $811,000 | – | 486,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 84,846,000 | $114,699,000 | 3.39% |
SYMPHONY ASSET MANAGEMENT LLC | 6,000,000 | $8,104,000 | 0.82% |
ZAZOVE ASSOCIATES LLC | 10,100,000 | $13,682,000 | 0.81% |
CAPSTONE INVESTMENT ADVISORS, LLC | 14,074,000 | $19,008,000 | 0.54% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 5,000,000 | $6,728,000 | 0.43% |
CSS LLC/IL | 6,251,000 | $8,433,000 | 0.42% |
SSI INVESTMENT MANAGEMENT LLC | 3,032,000 | $4,080,000 | 0.34% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,328,000 | $9,903,000 | 0.19% |
Nicholas Investment Partners, LP | 1,620,000 | $2,180,000 | 0.07% |
D. E. Shaw & Co., Inc. | 34,550,000 | $46,670,000 | 0.06% |